Regulations.gov document
Guidance for Industry on Labeling for Human Prescription Drug and Biological Products…
Notice · FDA-2005-D-0153 · posted Feb 25, 2013
Key facts
| Document ID | FDA-2005-D-0153-0004 |
|---|---|
| Title | Guidance for Industry on Labeling for Human Prescription Drug and Biological Products; Availability: Implementing the Physician Labeling Rule Content and Format Requirements; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2005-D-0153 |
| Posted | Feb 25, 2013 |
| FR document number | 2013-04195 |
| Comment period opens | Feb 25, 2013 |
| Effective date | Feb 25, 2013 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: